A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Allylprodine
Solabegron
Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Solabegron.
Allylprodine
Nylidrin
Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Nylidrin.
Allylprodine
Amibegron
Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Amibegron.
Allylprodine
Nebivolol
Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Nebivolol.
Allylprodine
Celiprolol
Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Celiprolol.
Allylprodine
Phendimetrazine
Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Phendimetrazine.
Allylprodine
Lorcaserin
The risk or severity of adverse effects can be increased when Lorcaserin is combined with Dihydroergocristine.
Allylprodine
Naxitamab
The risk or severity of hypertension can be increased when Dihydroergocristine is combined with Naxitamab.
Allylprodine
Loxoprofen
The risk or severity of hypertension can be increased when Loxoprofen is combined with Dihydroergocristine.
Allylprodine
Selpercatinib
The risk or severity of hypertension can be increased when Dihydroergocristine is combined with Selpercatinib.
Allylprodine
Lurasidone
The risk or severity of hypertension can be increased when Lurasidone is combined with Dihydroergocristine.
Allylprodine
Aripiprazole lauroxil
The risk or severity of hypertension can be increased when Dihydroergocristine is combined with Aripiprazole lauroxil.
Allylprodine
Terguride
The risk or severity of hypertension can be increased when Dihydroergocristine is combined with Terguride.
Allylprodine
Propiverine
The risk or severity of hypertension can be increased when Propiverine is combined with Dihydroergocristine.
Allylprodine
Propacetamol
The risk or severity of hypertension can be increased when Propacetamol is combined with Dihydroergocristine.
Allylprodine
Tolfenamic acid
The risk or severity of hypertension can be increased when Tolfenamic acid is combined with Dihydroergocristine.
Allylprodine
Parecoxib
The risk or severity of hypertension can be increased when Parecoxib is combined with Dihydroergocristine.
Allylprodine
Asenapine
The risk or severity of hypertension can be increased when Asenapine is combined with Dihydroergocristine.
Allylprodine
Mianserin
The risk or severity of hypertension can be increased when Mianserin is combined with Dihydroergocristine.
Allylprodine
Iloperidone
The risk or severity of hypertension can be increased when Iloperidone is combined with Dihydroergocristine.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3